Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
139M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
-8.74M
-
Total reported value, excl. options
-
$25M
-
Value change
-
-$15.5M
-
Put/Call ratio
-
1.52
-
Number of buys
-
25
-
Number of sells
-
-46
-
Price
-
$1.62
Significant Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q2 2017
95 filings reported holding ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") as of Q2 2017.
ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 139M outstanding shares and own 11.1% of the company stock.
Largest 10 shareholders include OppenheimerFunds, Inc. (3M shares), VANGUARD GROUP INC (2.71M shares), BlackRock Inc. (2.46M shares), MILLENNIUM MANAGEMENT LLC (1.48M shares), PERCEPTIVE ADVISORS LLC (847K shares), GEODE CAPITAL MANAGEMENT, LLC (560K shares), RENAISSANCE TECHNOLOGIES LLC (374K shares), GOLDMAN SACHS GROUP INC (316K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (304K shares), and ELEMENT CAPITAL MANAGEMENT LLC (294K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.